Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Brophy

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|November 12, 2019
External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data CommonsDavid Cheng, Jaime Ramos-Cejudo, David Tuck, et al.
Health Research Policy and Systems|December 14, 2022
Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigationJennifer La, Nathanael R Fillmore, Nhan V Do, et al.
Haematologica|April 2, 2026
Survival assessment of warfarin and international normalized ratio exposure in cancer-associated venous thromboembolism: Veterans Affairs healthcare system-based analysisJustine Ryu, Jennifer La, Rushad Patell, et al.
Journal of the American Academy of Dermatology|January 10, 2021
Risk factors for thick melanoma among veterans: A cross-sectional studyRebecca I Hartman, Jennifer La, Michael S Chang, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription databaseBenjamin G Fincke, Kerri Snyder, Colleen Cantillon, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 6, 2025
Pulmonary aspergillosis in US Veterans with COVID-19: a nationwide, retrospective cohort studyKaitlin Swinnerton, Nathanael R Fillmore, Ikwo Oboho, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Implementation of a Precision Oncology Program as an Exemplar of a Learning Health Care System in the VALouis Fiore, Ryan E Ferguson, Mary Brophy, et al.
Infection Control and Hospital Epidemiology|May 23, 2022
Coronavirus disease 2019 (COVID-19) hospitalization metrics that do not account for disease severity underestimate protection provided by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination and boosting: A retrospective cohort studyJune K Corrigan, Jennifer La, Nathanael R Fillmore, et al.
Eclinicalmedicine|March 12, 2025
Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction toolKaitlin Swinnerton, Nathanael R Fillmore, Austin Vo, et al.
Journal of the American Academy of Dermatology|May 20, 2022
Increased relative proportions of advanced melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results registryMichael S Chang, Jennifer La, Nicole Trepanowski, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|November 12, 2019
External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data CommonsDavid Cheng, Jaime Ramos-Cejudo, David Tuck, et al.
Health Research Policy and Systems|December 14, 2022
Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigationJennifer La, Nathanael R Fillmore, Nhan V Do, et al.
Haematologica|April 2, 2026
Survival assessment of warfarin and international normalized ratio exposure in cancer-associated venous thromboembolism: Veterans Affairs healthcare system-based analysisJustine Ryu, Jennifer La, Rushad Patell, et al.
Journal of the American Academy of Dermatology|January 10, 2021
Risk factors for thick melanoma among veterans: A cross-sectional studyRebecca I Hartman, Jennifer La, Michael S Chang, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription databaseBenjamin G Fincke, Kerri Snyder, Colleen Cantillon, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 6, 2025
Pulmonary aspergillosis in US Veterans with COVID-19: a nationwide, retrospective cohort studyKaitlin Swinnerton, Nathanael R Fillmore, Ikwo Oboho, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Implementation of a Precision Oncology Program as an Exemplar of a Learning Health Care System in the VALouis Fiore, Ryan E Ferguson, Mary Brophy, et al.
Infection Control and Hospital Epidemiology|May 23, 2022
Coronavirus disease 2019 (COVID-19) hospitalization metrics that do not account for disease severity underestimate protection provided by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination and boosting: A retrospective cohort studyJune K Corrigan, Jennifer La, Nathanael R Fillmore, et al.
Eclinicalmedicine|March 12, 2025
Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction toolKaitlin Swinnerton, Nathanael R Fillmore, Austin Vo, et al.
Journal of the American Academy of Dermatology|May 20, 2022
Increased relative proportions of advanced melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results registryMichael S Chang, Jennifer La, Nicole Trepanowski, et al.
Pageof 7